【24h】

The metabolism of CYP2C9 and CYP2C19 for gliclazide by homology modeling and docking study

机译:CYP2C9和CYP2C19代谢格列齐特的同源性建模和对接研究

获取原文

摘要

With homology modeling techniques, a 3D structure model of CYP2C19 was built and refined with molecular mechanics and molecular dynamics simulations. The refined model was assessed to be reasonable by Protile-3D and PROCHECK programs. With the aid of the automatic molecular docking, one substrate and two inhibitors were docked to CYP2C19 by InsightII/Affinity program. The docking results, which are in well agreement with the reported results, demonstrate that the refined model of CYP2C19 is reliable. Then, with the refined model of CYP2C19 and the crystal structure of CYP2C9, the metabolisms of them for gliclazide in two different metabolic pathways were studied and the results show that both enzymes have more favorable interaction energies and stronger affinity with gliclazide in methylhydroxylation pathway than in 6β-hydroxylation pathway. It is exciting that substrate inhibition phenomenon can be found in metabolisms of CYP2C9 and CYP2C19 for gliclazide in two metabolic pathways. Gliclazide can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in CYP2C9 and CYP2C19. These results are in well agreement with the kinetic experimental results.
机译:利用同源建模技术,利用分子力学和分子动力学模拟建立并完善了CYP2C19的3D结构模型。通过Protile-3D和PROCHECK程序,对改进后的模型进行了评估是合理的。在自动分子对接的帮助下,InsightII / Affinity程序将一种底物和两种抑制剂对接至CYP2C19。对接结果与报道的结果非常吻合,证明了CYP2C19的改进模型是可靠的。然后,利用CYP2C19的精细模型和CYP2C9的晶体结构,研究了格列齐特在两种不同代谢途径中的代谢,结果表明两种酶在甲基羟化途径中具有更好的相互作用能和与格列齐特的亲和力强。 6β-羟基化途径。令人兴奋的是,在格列齐特的两种代谢途径中,CYP2C9和CYP2C19的代谢中均可发现底物抑制现象。当格列齐特停靠在CYP2C9和CYP2C19的第二个活性位点时,格列齐特可以改变活性位点的构象,并明显降低活性位点中的格列齐特与酶之间的亲和力。这些结果与动力学实验结果非常吻合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号